What causes liver cancer

Liver cancer usually develops when chronic damage to the liver creates scarring (called cirrhosis), and damaged cells begin to grow abnormally. The most common causes are long-term hepatitis B or C infection, heavy alcohol use over many years, and fatty liver disease. Cirrhosis itself—regardless of what caused it—raises your risk significantly. A smaller number of cases occur without cirrhosis, but this is less common.

The process is not sudden. Liver cancer typically takes years or decades to develop. Your liver cells accumulate genetic changes from repeated injury, inflammation, and repair cycles. Eventually some cells stop responding to normal growth signals and become cancerous. Understanding what damaged your liver in the first place matters because it affects screening recommendations and sometimes treatment options.

Key Takeaways

  • Hepatitis B and C infections are the leading causes of liver cancer worldwide, especially when they become chronic and cause cirrhosis.
  • Cirrhosis from any cause—alcohol, hepatitis, fatty liver disease, or autoimmune conditions—significantly raises liver cancer risk even before cancer appears.
  • Heavy alcohol use over years damages liver cells and causes inflammation that can lead to cirrhosis and cancer.
  • Fatty liver disease, which can develop without alcohol use, is becoming an increasingly common risk factor for liver cancer.
  • People with known cirrhosis or chronic hepatitis usually need regular ultrasound screening because early detection changes treatment options.

Hepatitis B and C: The leading infectious causes

Chronic hepatitis B and hepatitis C infections cause more liver cancer cases than any other single factor. Both viruses attack liver cells, triggering inflammation that persists for years or decades. Over time, this chronic inflammation scars the liver and disrupts normal cell growth patterns.

Hepatitis B is transmitted through blood, sexual contact, or from mother to child during birth. Once infected, some people clear the virus naturally, but others develop chronic infection that lasts a lifetime. Chronic hepatitis B carriers have a measurable risk of liver cancer even without cirrhosis, though the risk rises sharply once cirrhosis develops.

Hepatitis C spreads primarily through blood-to-blood contact—historically through contaminated blood transfusions or shared needles, though new infections are now less common in countries with screening programs. Unlike hepatitis B, most people who contract hepatitis C do not clear it on their own. Modern antiviral medications can cure hepatitis C in most cases, which substantially lowers cancer risk if treatment happens before cirrhosis becomes severe.

Cirrhosis: The scarring that precedes most cases

Cirrhosis is the scarring of liver tissue that occurs after years of repeated injury. Once cirrhosis develops, the risk of liver cancer rises dramatically—roughly 1 to 5 percent of people with cirrhosis develop cancer each year, depending on the underlying cause and severity. The scarred tissue disrupts normal liver function and creates an environment where abnormal cell growth is more likely.

Cirrhosis can result from hepatitis infection, alcohol use, fatty liver disease, autoimmune hepatitis, hemochromatosis (iron overload), or primary biliary cholangitis. The cause matters for treatment planning, but the presence of cirrhosis itself is what most directly raises cancer risk. Some people develop liver cancer without cirrhosis, but this accounts for only 10 to 20 percent of cases.

Once cirrhosis is diagnosed, doctors typically recommend regular screening with ultrasound and sometimes blood tests for a protein called alpha-fetoprotein (AFP). This screening can catch cancer at earlier stages when treatment options are broader.

Alcohol use and liver damage

Heavy, long-term alcohol consumption damages liver cells through multiple mechanisms: direct toxicity, oxidative stress, and triggering inflammation. The liver metabolizes alcohol, and this process generates harmful byproducts that injure hepatocytes (liver cells). Over years, this injury causes inflammation, fibrosis (scarring), and eventually cirrhosis.

The amount and duration matter. There is no single threshold that applies to everyone, but generally, consuming more than 3 to 4 drinks daily for men or 2 to 3 drinks daily for women over many years raises the risk of cirrhosis. Once cirrhosis develops from alcohol use, the risk of liver cancer follows the same pattern as cirrhosis from other causes.

Alcohol-related liver disease can progress through stages: fatty liver (reversible), alcoholic hepatitis (inflammation), and cirrhosis (scarring). Stopping alcohol use at any stage can slow or halt progression, but cirrhosis itself is not reversible. People with alcohol-related cirrhosis benefit from the same screening protocols as those with cirrhosis from other causes.

Fatty liver disease and metabolic risk

Nonalcoholic fatty liver disease (NAFLD) has become increasingly common and is now a leading cause of liver cancer in developed countries. Fat accumulates in liver cells, triggering inflammation and oxidative stress. Over time, this can progress to cirrhosis, which then raises cancer risk.

NAFLD is strongly associated with obesity, type 2 diabetes, and metabolic syndrome. Unlike alcohol-related disease, it develops without significant alcohol consumption. A related condition, metabolic dysfunction-associated fatty liver disease (MAFLD), is the newer term used to describe the same process when it occurs alongside metabolic risk factors.

Many people have fatty liver without knowing it—it is often discovered incidentally on imaging done for other reasons. Progression to cirrhosis is not inevitable; some people have stable fatty liver for years. However, those who do develop cirrhosis from fatty liver disease face the same cancer risk as those with cirrhosis from other causes. Weight loss, blood sugar control, and management of metabolic risk factors can slow progression.

Other conditions that increase liver cancer risk

Several less common conditions raise liver cancer risk by damaging the liver or causing cirrhosis. Hemochromatosis causes the body to absorb and store too much iron, which damages liver cells over time. Autoimmune hepatitis occurs when the immune system attacks liver cells, causing chronic inflammation. Primary biliary cholangitis and primary sclerosing cholangitis are autoimmune conditions affecting the bile ducts.

Certain inherited metabolic disorders, including alpha-1 antitrypsin deficiency, also increase risk. People with any of these conditions who develop cirrhosis follow the same cancer risk trajectory as those with cirrhosis from hepatitis or alcohol use.

Additionally, some people are born with cirrhosis or develop it in childhood from genetic conditions. The underlying cause does not change the fact that cirrhosis itself is the major risk factor for cancer development.

Age, gender, and genetic factors

Liver cancer is more common in men than women, though the reasons are not entirely clear—it may reflect higher rates of hepatitis B and C infection in men, higher alcohol consumption, or biological differences in how the liver responds to injury. Age also matters: liver cancer is more common in people over 50, though it can occur at any age.

Certain genetic variations may influence how quickly someone develops cirrhosis or cancer after infection or injury, but these are not yet used clinically to predict individual risk. Family history of liver cancer is not a strong predictor unless it reflects shared exposure to hepatitis infection or inherited metabolic disease.

People of Asian and Pacific Islander descent have higher rates of hepatitis B infection due to historical epidemiology, which translates to higher liver cancer rates in these populations. This reflects infection patterns, not genetic predisposition to cancer.

Frequently Asked Questions

Can you get liver cancer without cirrhosis?

Yes, but it is less common. About 10 to 20 percent of liver cancers occur in people without cirrhosis, particularly in those with chronic hepatitis B infection or advanced fatty liver disease. However, cirrhosis remains the strongest risk factor and precedes most cases.

If I have hepatitis B or C, will I definitely get liver cancer?

No. Many people with chronic hepatitis B or C never develop cirrhosis or cancer, especially if they receive treatment. Hepatitis C can now be cured with antiviral medications in most cases. Hepatitis B cannot be cured, but antiviral medications can suppress the virus and reduce cancer risk. Regular screening is recommended for those with chronic infection.

Does fatty liver disease always turn into cancer?

No. Many people have fatty liver disease without progression to cirrhosis or cancer. However, those who do develop cirrhosis from fatty liver disease face increased cancer risk. Weight management, blood sugar control, and treatment of metabolic conditions can slow or prevent progression.

How long does it take for liver damage to become cancer?

There is no fixed timeline. It typically takes years or decades of chronic injury before cirrhosis develops, and additional years before cancer appears. Some people with cirrhosis never develop cancer, while others do within a few years. This is why screening is recommended for people with known cirrhosis rather than waiting for symptoms.

What should I do if I think I have a risk factor for liver cancer?

Talk with your doctor about your specific risk factors—hepatitis status, alcohol use, weight, diabetes, or family history. Your doctor can order blood tests and imaging to check for liver disease and, if needed, refer you to a liver specialist. Early detection of cirrhosis or hepatitis allows for screening and treatment that can reduce cancer risk.